Dr. Melecia Fuentes, M.D

NPI: 1083713952
Total Payments
$7,400
2024 Payments
$1,176
Companies
29
Transactions
438
Medicare Patients
2,875
Medicare Billing
$247,076

Payment Breakdown by Category

Food & Beverage$7,355 (99.4%)
Education$44.49 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,355 434 99.4%
Education $44.49 4 0.6%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,499 99 $0 (2024)
AstraZeneca Pharmaceuticals LP $999.90 47 $0 (2024)
Lilly USA, LLC $955.97 82 $0 (2024)
Amgen Inc. $623.83 34 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $541.36 18 $0 (2024)
SANOFI-AVENTIS U.S. LLC $439.36 26 $0 (2021)
ABBVIE INC. $374.64 22 $0 (2024)
Amarin Pharma Inc. $273.65 21 $0 (2021)
Janssen Pharmaceuticals, Inc $266.10 6 $0 (2024)
Kowa Pharmaceuticals America, Inc. $255.33 21 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,176 66 Bayer Healthcare Pharmaceuticals Inc. ($348.67)
2023 $1,319 78 Lilly USA, LLC ($367.25)
2022 $664.45 40 Novo Nordisk Inc ($221.27)
2021 $680.18 45 Novo Nordisk Inc ($187.55)
2020 $823.60 52 AstraZeneca Pharmaceuticals LP ($267.22)
2019 $667.41 36 AstraZeneca Pharmaceuticals LP ($209.49)
2018 $642.09 32 AstraZeneca Pharmaceuticals LP ($196.16)
2017 $1,428 89 AstraZeneca Pharmaceuticals LP ($285.22)

All Payment Transactions

438 individual payment records from CMS Open Payments — Page 3 of 18

Date Company Product Nature Form Amount Type
03/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.01 General
Category: NEUROSCIENCE
03/15/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $25.32 General
Category: Cardiovascular & Metabolism
03/08/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $21.44 General
Category: Diabetes
03/07/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.85 General
Category: Inflammation
03/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.59 General
Category: NEUROSCIENCE
02/29/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $8.21 General
Category: Diabetes
02/20/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $11.28 General
Category: Diabetes
02/16/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.67 General
Category: Cardiovascular and Metabolism
02/12/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $18.67 General
Category: Diabetes
02/01/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $9.74 General
Category: Diabetes
02/01/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $2.45 General
Category: Diabetes
01/27/2024 Lilly USA, LLC Food and Beverage In-kind items and services $20.90 General
01/22/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $6.10 General
Category: Diabetes
01/12/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.98 General
Category: Diabetes
01/06/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $20.73 General
Category: Diabetes
01/05/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $3.35 General
Category: Diabetes
12/28/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $7.27 General
Category: Diabetes
12/22/2023 Alvogen Inc TERIPARATIDE (Drug) Food and Beverage In-kind items and services $18.47 General
Category: OSTEOPOROSIS
12/18/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.81 General
Category: Gastroenterology
12/12/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $12.93 General
Category: Inflammation
12/08/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.66 General
Category: NEUROSCIENCE
12/02/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.73 General
Category: Cardiovascular and Metabolism
12/01/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $13.89 General
Category: Diabetes
11/11/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $17.79 General
Category: Diabetes
11/08/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $6.85 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 333 578 $107,374 $35,906
2022 13 605 1,046 $91,750 $60,429
2021 20 770 1,332 $106,970 $68,599
2020 20 1,167 2,390 $151,095 $82,141
Total Patients
2,875
Total Services
5,346
Medicare Billing
$247,076
Procedure Codes
63

All Medicare Procedures & Services

63 procedure records from CMS Medicare Utilization — Page 3 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0444 Annual depression screening, 15 minutes Office 2020 62 62 $1,550 $1,096 70.7%
90674 Vaccine for influenza for administration into muscle, 0.5 ml dosage Office 2020 30 30 $1,500 $876.90 58.5%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 43 82 $2,460 $792.94 32.2%
96360 Hydration infusion into a vein 31 minutes to 1 hour Office 2020 21 29 $2,175 $653.17 30.0%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 44 49 $2,695 $575.34 21.3%
36415 Insertion of needle into vein for collection of blood sample Office 2020 116 172 $1,720 $505.32 29.4%
G0008 Administration of influenza virus vaccine Office 2020 30 30 $900.00 $486.60 54.1%
G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem Office 2020 11 12 $1,200 $457.43 38.1%
81003 Automated urinalysis test Office 2020 55 104 $1,560 $229.95 14.7%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2020 29 190 $3,325 $74.92 2.3%
J7030 Infusion, normal saline solution , 1000 cc Office 2020 15 25 $250.00 $46.92 18.8%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2020 26 110 $825.00 $46.64 5.7%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2020 13 92 $460.00 $7.66 1.7%

About Dr. Melecia Fuentes, M.D

Dr. Melecia Fuentes, M.D is a Family Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083713952.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melecia Fuentes, M.D has received a total of $7,400 in payments from pharmaceutical and medical device companies, with $1,176 received in 2024. These payments were reported across 438 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,355).

As a Medicare-enrolled provider, Fuentes has provided services to 2,875 Medicare beneficiaries, totaling 5,346 services with total Medicare billing of $247,076. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Weslaco, TX
  • Active Since 09/21/2006
  • Last Updated 07/03/2019
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1083713952

Products in Payments

  • FARXIGA (Drug) $890.27
  • Ozempic (Drug) $780.89
  • MOUNJARO (Drug) $559.71
  • Kerendia (Drug) $541.36
  • JARDIANCE (Drug) $356.80
  • Rybelsus (Drug) $297.10
  • Vascepa (Drug) $273.65
  • Livalo (Drug) $255.33
  • Victoza (Drug) $240.66
  • TOUJEO (Drug) $198.59
  • TRULICITY (Drug) $174.03
  • Prolia (Biological) $168.43
  • XARELTO (Drug) $165.42
  • Otezla (Drug) $148.96
  • Aimovig (Biological) $148.50
  • SOLIQUA (Drug) $135.84
  • VRAYLAR (Drug) $128.66
  • Synthroid (Drug) $125.80
  • BYDUREON (Drug) $109.63
  • INVOKANA (Drug) $100.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Weslaco